Article Information
History
- August 1, 2024.
Article Versions
- Version 1 (July 22, 2024 - 18:55).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Emmanuelle Cacoub1,2,
- Nathalie Barreto Lefebvre1,
- Dimitrije Milunov1,
- Manish Sarkar1,* and
- Soham Saha1,*
- 1Medinsights SAS, 8 rue Milton, 75009 Paris, France
- 2ESCP Business School, 3 Rue Armand Moisant, 75015 Paris, France
- ↵*Co-corresponding authors:
Soham Saha, Medinsights SAS, Paris, France, Email: soham.saha{at}medinsights.fr Manish Sarkar, Medinsights SAS, Paris, France, Email: manish.sarkar{at}medinsights.fr
Posted August 01, 2024.
Quantifying hope: An EU perspective of rare disease therapeutic space and market dynamics
